Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Combined [68Ga]Ga-DOTA-SST Analogues and [18F]FDG PET/CT in the Management of GEP-NENs: A Systematic Review
Luciano Carideo, Daniela Prosperi, Francesco Panzuto, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 7, pp. 1032-1032
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

MANAGEMENT OF ENDOCRINE DISEASE: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion
Jacques Young, Magalie Haissaguerre, Oceana Viera-Pinto, et al.
European Journal of Endocrinology (2020) Vol. 182, Iss. 4, pp. R29-R58
Open Access | Times Cited: 178
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
David L. Chan, Aimee R. Hayes, Ioannis Karfis, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 4, pp. 549-555
Open Access | Times Cited: 43
Distinguishing Cushing's disease from the ectopic ACTH syndrome: Needles in a haystack or hiding in plain sight?
Aimee R. Hayes, Ashley Grossman
Journal of Neuroendocrinology (2022) Vol. 34, Iss. 8
Open Access | Times Cited: 29
Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
Isabella Reccia, Madhava Pai, Kumar Jayant, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1861-1861
Open Access | Times Cited: 15
Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms
Roberta Modica, Elio Benevento, Alessia Liccardi, et al.
Minerva Endocrinology (2024) Vol. 49, Iss. 2
Closed Access | Times Cited: 6
Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
Martine Bocchini, Fabio Nicolini, Stefano Severi, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
Diletta Calabrò, Giulia Argalia, Valentina Ambrosini
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1059-1059
Open Access | Times Cited: 39
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
Virginia Liberini, Martin W. Huellner, Séréna Grimaldi, et al.
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1083-1083
Open Access | Times Cited: 37
Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT
Lamiaa Zidan, Amir Iravani, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2020) Vol. 48, Iss. 1, pp. 204-216
Closed Access | Times Cited: 35
Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
Virginia Liberini, Bruno De Santi, Osvaldo Rampado, et al.
EJNMMI Physics (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response—AJR Expert Panel Narrative Review
Samuel J. Galgano, Amir Iravani, Lisa Bodei, et al.
American Journal of Roentgenology (2022) Vol. 218, Iss. 5, pp. 767-780
Closed Access | Times Cited: 21
A Systematic Review on Combined [18F]FDG and 68Ga-SSA PET/CT in Pulmonary Carcinoid
Daniela Prosperi, Luciano Carideo, Vincenzo Russo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3719-3719
Open Access | Times Cited: 13
Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management
Cody R. Criss, Mina S. Makary
Current Oncology (2024) Vol. 31, Iss. 4, pp. 2076-2091
Open Access | Times Cited: 4
Gastrointestinal neuroendocrine tumor syndromes (GI-NETS)
Tetsuhide Ito, Robert T. Jensen
Elsevier eBooks (2025)
Closed Access
Management of Small Bowel Neuroendocrine Tumors
Aaron T. Scott, James R. Howe
Surgical Oncology Clinics of North America (2020) Vol. 29, Iss. 2, pp. 223-241
Closed Access | Times Cited: 24
The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Aimee R. Hayes, Luke Furtado O’Mahony, Ann‐Marie Quigley, et al.
Clinical Nuclear Medicine (2021) Vol. 47, Iss. 1, pp. 26-35
Closed Access | Times Cited: 23
Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from 68Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine Tumors
Philippe Thuillier, Virginia Liberini, Séréna Grimaldi, et al.
Journal of Nuclear Medicine (2021) Vol. 63, Iss. 7, pp. 1014-1020
Open Access | Times Cited: 22
Molecular Imaging of Neuroendocrine Neoplasms
Julie Refardt, Johannes Hofland, Damian Wild, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. e2662-e2670
Open Access | Times Cited: 16
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors
Ludovica Magi, Daniela Prosperi, Giuseppe Lamberti, et al.
Endocrine (2022) Vol. 76, Iss. 2, pp. 484-490
Open Access | Times Cited: 15
Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update
Daniela Prosperi, Guido Gentiloni Silveri, Francesco Panzuto, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6836-6836
Open Access | Times Cited: 15
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
Francesco Panzuto, Manuela Albertelli, Maria Luisa De Rimini, et al.
Journal of Endocrinological Investigation (2024) Vol. 48, Iss. 1, pp. 23-36
Open Access | Times Cited: 3
Changing biological behaviour of NETs during the evolution of the disease: progress on progression
Krystallenia Alexandraki, Ariadni Spyroglou, Stylianos Kykalos, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 5, pp. R121-R140
Open Access | Times Cited: 19
Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours
Barbara Kreppel, Maria A. Gonzalez‐Carmona, Georg Feldmann, et al.
Nuklearmedizin - NuclearMedicine (2021) Vol. 60, Iss. 05, pp. 344-354
Closed Access | Times Cited: 19
Machine Learning-Based Noninvasive Quantification of Single-Imaging Session Dual-Tracer 18F-FDG and 68Ga-DOTATATE Dynamic PET-CT in Oncology
Wenxiang Ding, Jiangyuan Yu, Chaojie Zheng, et al.
IEEE Transactions on Medical Imaging (2021) Vol. 41, Iss. 2, pp. 347-359
Closed Access | Times Cited: 19
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors
Xin Lou, Yi Qin, Xiaowu Xu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188782-188782
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top